Abbott vs Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings?
Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand f...
Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand f...

Volta's strategic moves highlight a shift in AI infrastructure, addressing market gaps and potentially reshaping startup access to resources. The post Volta secures $10B partnership and $300M raise, co-led by a16z, at a $2.4B valuation appeared first on Crypt…
- Seasoned digital health growth executive with demonstrated ability to build revenue and drive disciplined expansion - LOS ANGELES, Aug. 04, 2026 ...

Nvidia (NASDAQ: NVDA) is scheduled to report its second-quarter fiscal 2027 results on Aug. 26, and the timing raises what has lately become a familiar question for Nvidia investors: Is the stock worth buying ahead of the earnings announcement? The major arti…
New York, Aug. 04, 2026 (GLOBE NEWSWIRE) -- AlixPartners, the global consulting firm, today announced the acquisition of Artium, a leading agentic AI software consulting firm specializing in building and launching enterprise-grade agents for clients including…